Related Experiment Video
Updated: May 4, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Targeting a G-protein-coupled receptor overexpressed in endocrine tumors by magnetic nanoparticles to induce cell
Claire Sanchez1, Darine El Hajj Diab, Vincent Connord
1EA 4552, Université de Toulouse 3 , Toulouse, France.
Abstract:
Nanotherapy using targeted magnetic nanoparticles grafted with peptidic ligands of receptors overexpressed in cancers is a promising therapeutic strategy. However, nanoconjugation of peptides can dramatically affect their properties with respect to receptor recognition, mechanism of internalization, intracellular trafficking, and fate. Furthermore, investigations are needed to better understand the mechanism whereby application of an alternating magnetic field to cells containing targeted nanoparticles induces cell death. Here, we designed a nanoplatform (termed MG-IONP-DY647) composed of an iron oxide nanocrystal decorated with a ligand of a G-protein coupled receptor, the cholecystokinin-2 receptor (CCK2R) that is overexpressed in several malignant cancers. MG-IONP-DY647 did not stimulate inflammasome of Raw 264.7 macrophages. They recognized cells expressing CCK2R with a high specificity, subsequently internalized via a mechanism involving recruitment of β-arrestins, clathrin-coated pits, and dynamin and were directed to lysosomes. Binding and internalization of MG-IONP-DY647 were dependent on the density of the ligand at the nanoparticle surface and were slowed down relative to free ligand. Trafficking of CCK2R internalized with the nanoparticles was slightly modified relative to CCK2R internalized in response to free ligand. Application of an alternating magnetic field to cells containing MG-IONP-DY647 induced apoptosis and cell death through a lysosomal death pathway, demonstrating that cell death is triggered even though nanoparticles of low thermal power are internalized in minute amounts by the cells. Together with pioneer findings using iron oxide nanoparticles targeting tumoral cells expressing epidermal growth factor receptor, these data represent a solid basis for future studies aiming at establishing the proof-of-concept of nanotherapy of cancers using ligand-grafted magnetic nanoparticles specifically internalized via cell surface receptors.
Insights
Targeted magnetic nanoparticles (MG-IONP-DY647) carrying cancer-targeting ligands show specific cell uptake and trigger cancer cell death via an alternating magnetic field, paving the way for novel nanotherapies.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Research
Background:
- Targeted magnetic nanoparticles offer a promising cancer nanotherapy approach.
- Peptide conjugation impacts nanoparticle behavior and cellular interactions.
- Understanding magnetic field-induced cell death mechanisms is crucial.
Purpose of the Study:
- To design and characterize a novel nanoplatform (MG-IONP-DY647) for targeted cancer therapy.
- To investigate the cellular uptake, trafficking, and specificity of MG-IONP-DY647.
- To elucidate the mechanism of cell death induced by alternating magnetic fields in nanoparticle-loaded cancer cells.
Main Methods:
- Synthesis and characterization of iron oxide nanocrystals grafted with CCK2R ligands (MG-IONP-DY647).
- Assessment of inflammasome activation in macrophages.
- Evaluation of cell recognition, internalization pathways (β-arrestin, clathrin, dynamin), and lysosomal trafficking in CCK2R-expressing cells.
- Analysis of ligand density effects on binding and internalization.
- Induction of apoptosis and cell death using alternating magnetic fields.
Main Results:
- MG-IONP-DY647 demonstrated high specificity for CCK2R-expressing cells without stimulating inflammasome.
- Internalization occurred via β-arrestin, clathrin-coated pits, and dynamin, with lysosomal trafficking.
- Ligand density influenced binding and internalization rates.
- Alternating magnetic field application induced apoptosis and cell death through a lysosomal pathway, even with low nanoparticle uptake.
Conclusions:
- The designed nanoplatform (MG-IONP-DY647) is a specific and effective tool for targeting CCK2R-overexpressing cancer cells.
- Nanoparticle-mediated magnetic hyperthermia can induce cancer cell death via lysosomal pathways.
- These findings support the potential of ligand-grafted magnetic nanoparticles in cancer nanotherapy development.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle

